Amfex AM

A triple-action respiratory formulation combining mucoregulator (acebrophylline), leukotriene antagonist (montelukast), and antihistamine (fexofenadine). (Barnes PJ, 2006) Provides comprehensive management of bronchospasm, inflammation and allergic components in COPD and asthma. (Currie GP, 2005) The acebrophylline enhances mucociliary clearance by 65%. (Zuin R, 2004)

Indication

• Chronic obstructive pulmonary disease

• Bronchial asthma

• Allergic bronchitis

• Chronic cough variant asthma

Side Effects

• Headache

• Dry throat

• Mild sedation

• Palpitations (rare)